CELZ

Creative Medical Technology Holdings, Inc.

4.01 USD
-0.13 (-3.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Creative Medical Technology Holdings, Inc. stock is down -6.74% since 30 days ago. The next earnings date is Apr 1, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 8 February’s closed higher than January.

About Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc. focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness.